Sarofim Equity Fund Market Value

SRFMX Fund  USD 13.72  0.25  1.86%   
Sarofim Equity's market value is the price at which a share of Sarofim Equity trades on a public exchange. It measures the collective expectations of Sarofim Equity investors about its performance. Sarofim Equity is trading at 13.72 as of the 15th of March 2025; that is 1.86 percent increase since the beginning of the trading day. The fund's open price was 13.47.
With this module, you can estimate the performance of a buy and hold strategy of Sarofim Equity and determine expected loss or profit from investing in Sarofim Equity over a given investment horizon. Check out Sarofim Equity Correlation, Sarofim Equity Volatility and Sarofim Equity Alpha and Beta module to complement your research on Sarofim Equity.
Symbol

Please note, there is a significant difference between Sarofim Equity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sarofim Equity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sarofim Equity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sarofim Equity 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sarofim Equity's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sarofim Equity.
0.00
12/15/2024
No Change 0.00  0.0 
In 3 months and 1 day
03/15/2025
0.00
If you would invest  0.00  in Sarofim Equity on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Sarofim Equity or generate 0.0% return on investment in Sarofim Equity over 90 days. Sarofim Equity is related to or competes with Barings Global, Franklin Mutual, Ab Global, Aqr Global, Nuveen Global, Rbb Fund, and Ab Global. Under normal circumstances, the fund invests at least 80 percent of its net assets, plus any borrowings for investment p... More

Sarofim Equity Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sarofim Equity's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sarofim Equity upside and downside potential and time the market with a certain degree of confidence.

Sarofim Equity Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Sarofim Equity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sarofim Equity's standard deviation. In reality, there are many statistical measures that can use Sarofim Equity historical prices to predict the future Sarofim Equity's volatility.
Hype
Prediction
LowEstimatedHigh
11.6513.7215.79
Details
Intrinsic
Valuation
LowRealHigh
12.0514.1216.19
Details
Naive
Forecast
LowNextHigh
11.2113.2715.34
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
13.7714.3815.00
Details

Sarofim Equity Backtested Returns

Sarofim Equity owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the fund had a -0.17 % return per unit of risk over the last 3 months. Sarofim Equity exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sarofim Equity's Risk Adjusted Performance of (0.14), variance of 3.97, and Coefficient Of Variation of (606.15) to confirm the risk estimate we provide. The entity has a beta of 0.47, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sarofim Equity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sarofim Equity is expected to be smaller as well.

Auto-correlation

    
  0.10  

Insignificant predictability

Sarofim Equity has insignificant predictability. Overlapping area represents the amount of predictability between Sarofim Equity time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sarofim Equity price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Sarofim Equity price fluctuation can be explain by its past prices.
Correlation Coefficient0.1
Spearman Rank Test-0.26
Residual Average0.0
Price Variance0.06

Sarofim Equity lagged returns against current returns

Autocorrelation, which is Sarofim Equity mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sarofim Equity's mutual fund expected returns. We can calculate the autocorrelation of Sarofim Equity returns to help us make a trade decision. For example, suppose you find that Sarofim Equity has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Sarofim Equity regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sarofim Equity mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sarofim Equity mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sarofim Equity mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Sarofim Equity Lagged Returns

When evaluating Sarofim Equity's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sarofim Equity mutual fund have on its future price. Sarofim Equity autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sarofim Equity autocorrelation shows the relationship between Sarofim Equity mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Sarofim Equity.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Sarofim Mutual Fund

Sarofim Equity financial ratios help investors to determine whether Sarofim Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarofim with respect to the benefits of owning Sarofim Equity security.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets